G. YENİDÜNYA YALIN Et Al. , "Does MEN1 variant (p.Ser183Cys) affect the response to DA therapy in a young prolactinoma patient without other components of MEN1 syndrome?," Endobridge 2018 , Antalya, Turkey, pp.9, 2018
YENİDÜNYA YALIN, G. Et Al. 2018. Does MEN1 variant (p.Ser183Cys) affect the response to DA therapy in a young prolactinoma patient without other components of MEN1 syndrome?. Endobridge 2018 , (Antalya, Turkey), 9.
YENİDÜNYA YALIN, G., TUNCER KILINÇ, F. N., doğanşen, s., & YARMAN, E. S., (2018). Does MEN1 variant (p.Ser183Cys) affect the response to DA therapy in a young prolactinoma patient without other components of MEN1 syndrome? . Endobridge 2018 (pp.9). Antalya, Turkey
YENİDÜNYA YALIN, Gülşah Et Al. "Does MEN1 variant (p.Ser183Cys) affect the response to DA therapy in a young prolactinoma patient without other components of MEN1 syndrome?," Endobridge 2018, Antalya, Turkey, 2018
YENİDÜNYA YALIN, Gülşah Y. Et Al. "Does MEN1 variant (p.Ser183Cys) affect the response to DA therapy in a young prolactinoma patient without other components of MEN1 syndrome?." Endobridge 2018 , Antalya, Turkey, pp.9, 2018
YENİDÜNYA YALIN, G. Et Al. (2018) . "Does MEN1 variant (p.Ser183Cys) affect the response to DA therapy in a young prolactinoma patient without other components of MEN1 syndrome?." Endobridge 2018 , Antalya, Turkey, p.9.
@conferencepaper{conferencepaper, author={Gülşah YENİDÜNYA YALIN Et Al. }, title={Does MEN1 variant (p.Ser183Cys) affect the response to DA therapy in a young prolactinoma patient without other components of MEN1 syndrome?}, congress name={Endobridge 2018}, city={Antalya}, country={Turkey}, year={2018}, pages={9} }